Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
This guide explains What Is A Stock Market Index and why it matters for portfolios. See how indices track groups of stocks and influence returns.
27,346 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Investing in small biotech stocks offers the potential for outsized gains — but only with a clear process. This guide...
ASML is set to report Q2 results on July 15, 2026, with investors eyeing an reaffirmed or higher FY2026 revenue targe...
Today’s market shows a blend of volatility and opportunity. Planet Labs led a surge on strong earnings, while broader...
A high-profile insider sale at LegalZoom has investors asking questions. This article breaks down what the move could...
Robinhood's stock dropped about 6% after the company unveiled a $1.5 billion buyback. Yet investors remain skeptical ...
Investors are buzzing about a potential leadership transition at Nvidia. Here is a concise view of how a Huang exit c...
A long-standing storage supplier sits at the center of AI data growth. This article explains why the market may be un...
Three under-the-radar high-yield ETFs are delivering higher income in a market where cash yields rise. This report br...
Fairholme trimmed its stake in The St. Joe Company, but that doesn’t mean the stock isn’t worth a closer look. Here’s...
A mid-year 13F filing shows Sone Capital Management increasing its MarketAxess position. This article breaks down wha...
As SpaceX gears up for a potential June 2026 IPO, investors are flocking to Rocket Lab as the leading public substitu...